BHVN
BRL (BHVN)
NYSE
$15.09-$0.41 (-2.65%)
Price as of Jun 23, 2026 6:39 PM EDT
  • $1.2B
    Market Cap
  • 7.19%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
JANUS HENDERSON GROUP PLC
16.56%
17.5M
+16.1M (+91.97%)
Mar 31, 2026
BLACKROCK, INC.
10.60%
11.2M
+1.8M (+15.81%)
Mar 31, 2026
SUVRETTA CAPITAL MANAGEMENT, LLC
9.72%
10.3M
0 (0.00%)
Mar 31, 2026
STIFEL FINANCIAL CORP
9.39%
9.9M
+1,029 (+0.01%)
Mar 31, 2026
BLACKROCK FUNDING, INC. /DE
7.24%
7.7M
+789,833 (+10.30%)
Dec 31, 2024
STATE STREET CORP
6.25%
6.6M
+902,316 (+13.63%)
Mar 31, 2026
INFINITUM ASSET MANAGEMENT, LLC
5.90%
6.3M
0 (0.00%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions1.1B (88.07%)
  • Mutual Funds111.0M (8.87%)
  • Insiders38.2M (3.06%)
  • Other0 (0.00%)

Insider Transactions

  • 3.06% (38.2M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $9.5M
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Mehta Kishan
Gift
Mar 17, 2026
$0.00
17,342
$0.00
5,320
Mehta Kishan
Gift
Mar 17, 2026
$0.00
17,342
$0.00
17,342
Car Bruce
Chief Scientific Officer
Award
Feb 27, 2026
$0.00
175,000
$0.00
175,000
Buten Matthew
Chief Financial Officer
Exempt
Jan 05, 2026
$0.00
4,250
$0.00
8,500
Car Bruce
Chief Scientific Officer
Exempt
Jan 05, 2026
$0.00
4,750
$0.00
9,500
Clark George C.
VP, Chief Accounting Officer
Exempt
Jan 05, 2026
$0.00
2,500
$0.00
5,000
Gentile Kimberly
SVP, Clinical Operations
Exempt
Jan 05, 2026
$0.00
3,750
$0.00
7,500
Buten Matthew
Chief Financial Officer
Exempt
Jan 05, 2026
$0.00
4,250
$0.00
198,246
Car Bruce
Chief Scientific Officer
Exempt
Jan 05, 2026
$0.00
4,750
$0.00
10,096
Clark George C.
VP, Chief Accounting Officer
Exempt
Jan 05, 2026
$0.00
2,500
$0.00
68,095
Gentile Kimberly
SVP, Clinical Operations
Exempt
Jan 05, 2026
$0.00
3,750
$0.00
101,513
Buten Matthew
Chief Financial Officer
In Kind
Jan 05, 2026
$25,758.42
2,594
$9.93
195,652
Car Bruce
Chief Scientific Officer
In Kind
Jan 05, 2026
$23,643.33
2,381
$9.93
7,715
Clark George C.
VP, Chief Accounting Officer
In Kind
Jan 05, 2026
$11,091.81
1,117
$9.93
66,978
Gentile Kimberly
SVP, Clinical Operations
In Kind
Jan 05, 2026
$19,423.08
1,956
$9.93
99,557
Coric Vlad
Chief Executive Officer
Buy
Nov 13, 2025
$2.5M
333,333
$7.50
1.2M
Coric Vlad
Chief Executive Officer
Buy
Nov 13, 2025
$2.5M
333,333
$7.50
740,546
GREGORY JULIA P
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
Mehta Kishan
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
Bailey Gregory
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
CHILDS JOHN W
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
Heffernan Michael Thomas
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
Antonijevic Irina
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
HUGIN ROBERT J
Award
May 05, 2025
$0.00
31,716
$0.00
31,716
CHILDS JOHN W
Buy
Mar 04, 2025
$759,647.50
25,000
$30.39
2.3M
CHILDS JOHN W
Buy
Mar 04, 2025
$104,468.74
3,400
$30.73
24,452
CHILDS JOHN W
Buy
Mar 04, 2025
$104,468.74
3,400
$30.73
76,570
CHILDS JOHN W
Buy
Mar 04, 2025
$27,653.49
900
$30.73
25,291
Coric Vlad
Chief Executive Officer
Award
Jan 05, 2025
$0.00
343,000
$0.00
343,000
Clark George C.
VP, Chief Accounting Officer
Award
Jan 05, 2025
$0.00
30,000
$0.00
30,000